Also, in AD patients, CCR2 expression decreases in circulating monocytes whereas the levels of plasma CCL2 were increased, suggesting systemic immunologic dysfunction CCR2-CCL2 axis (141, 142) (Figure 1). This evidence concerns the gene CCL2 and Alzheimer disease.